文献速递神经肿瘤

Hydroset颅骨成形术作为垫圈密封与鼻中隔瓣颅底闭合辅助手段的安全性与有效性:病例对照研究

Safety and efficacy of hydroset cranioplasty as an adjunct to gasket-seal and nasoseptal flap closure of the skull base. A case-controlled study.
PubMed 文献 · Acta Neurochir (Wien) · 2024-06-08

该病例对照研究纳入2015至2023年首次内镜下经鼻切除鞍上脑膜瘤和颅咽管瘤的70例患者,比较加用Hydroset(羟基磷灰石)颅骨成形术(20例)与仅用垫圈密封和鼻中隔瓣闭合(50例)的脑脊液漏率及鼻腔并发症。Hydroset组脑脊液漏5% vs 对照组12%(p=0.38),脑脊液分流使用率75%(15/20)vs 94%(47/50)(p=0.02),SNOT-22评分无显著差异。作者认为羟基磷灰石重建在垫圈密封和鼻中隔瓣基础上改善了脑脊液漏控制,且无显著相关并发症,前提是骨水泥被血管化组织完全覆盖。

要点

  • Hydroset组脑脊液漏5% vs 对照组12%(p=0.38),差异未达统计学显著。
  • Hydroset组脑脊液分流使用率75%(15/20)vs 对照组94%(47/50)(p=0.02)。
  • SNOT-22评分Hydroset组平均22.45 vs 对照组平均25.90(p=0.58),无显著差异。

核心结论

  • 作者认为羟基磷灰石重建在垫圈密封和鼻中隔瓣基础上改善了脑脊液漏控制,且无显著相关并发症,前提是骨水泥被血管化组织完全覆盖。

研究设计与样本

  • 病例对照研究,查询2015至2023年前瞻性数据库,纳入首次内镜下经鼻切除鞍上脑膜瘤和颅咽管瘤的患者70例。
  • Hydroset组20例(脑膜瘤12例,颅咽管瘤8例),对照组50例(脑膜瘤25例,颅咽管瘤25例)。
  • 比较 demographics、技术因素和术后结局(SNOT-22)。

主要发现

  • 脑脊液分流使用率Hydroset组75%(15/20)vs 对照组94%(47/50)(p=0.02)。
  • 脑脊液漏发生率Hydroset组5% vs 对照组12%(p=0.38)。
  • Hydroset组1例患者需要延迟鼻部清创。
  • SNOT-22评分Hydroset组平均22.45 vs 对照组平均25.90(p=0.58),组间鼻窦鼻腔症状无显著差异。

临床怎么用

  • 作者认为羟基磷灰石重建在垫圈密封和鼻中隔瓣基础上改善了脑脊液漏控制,且无显著相关并发症,前提是骨水泥被血管化组织完全覆盖。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cerebrospinal fluid leak after endoscopic skull base surgery remains a significant complication. Several investigators have suggested Hydroset cranioplasty to reduce leak rates. We investigated our early experience with Hydroset and compared the rate of nasal complications and CSF leak rates with case-controlled historic controls. METHODS: We queried a prospective database of patients undergoing first time endoscopic, endonasal resection of suprasellar meningiomas and craniopharyngiomas from 2015 to 2023. We compared cases closed with a gasket seal, Hydroset, and a nasoseptal flap with those closed with only a gasket seal and nasoseptal flap. Demographics, technical considerations and postoperative outcomes (SNOT-22) were compared. RESULTS: Seventy patients met inclusion criteria, twenty patients in the Hydroset group (meningioma n = 12; craniopharyngioma n = 8) and 50 control patients (meningioma n = 25; craniopharyngioma n = 25). CSF diversion was used in fewer Hydroset patients (75%, 15/20) compared with control group (94%, 47/50; p = 0.02). CSF leak was less frequent in the Hydroset than the control group (5% versus 12%, p = 0.38). One Hydroset patient required delayed nasal debridement. SNOT-22 responses demonstrated no significant difference in sinonasal complaints between groups (Hydroset average SNOT-22 score 22.45, control average SNOT-22 score 25.90; p = 0.58). CONCLUSIONS: We demonstrate that hydroxyapatite reconstruction leads to improved CSF leak control above that provided by the gasket-seal and nasoseptal flap, without significant associated morbidity as long as the cement is fully covered with vascularized tissue.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Desai R, Kapur Z, Hammond B, et al. Safety and efficacy of hydroset cranioplasty as an adjunct to gasket-seal and nasoseptal flap closure of the skull base. A case-controlled study. Acta Neurochir (Wien). 2024. PMID: 38850489. doi:10.1007/s00701-024-06134-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。